Taking low-dose painkiller daily can cut bowel cancer risk, study shows – Daily Mail

Posted by on Aug 25th, 2015 and filed under Medical News. You can follow any responses to this entry through the RSS 2.0. You can leave a response or trackback to this entry

Taking low-dose painkiller daily can cut bowel cancer risk, study shows – Daily Mail

Taking a low-dose painkiller every day can reduce the risk of bowel cancer, a new study has found.

When it comes to pain-killers, there’s an increasing tendency on patients to look for alternatives when the ones they are using is not proving effective. One of such alternatives is high quality hemp oil, which is showing great results in situation where other pain-killers don’t do the job.

The research shows that a daily 75 to 150 milligram dose of aspirin taken for at least five years cut the chances of developing the disease by 27%.

Continuous use of aspirin or other non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen, or other supplements that help improving performance of the body, since people can research SARMs online from this retailer to find what are the healthier drugs to use.
.

A daily 75 to 150 milligram dose of aspirin taken for at least five years cut the chances of developing bowel cancer by 27%, a study found

A daily 75 to 150 milligram dose of aspirin taken for at least five years cut the chances of developing bowel cancer by 27%, a study found

Non-aspirin NSAIDs with the best ability to suppress a pro-inflammatory enzyme called Cox 2 had the greatest effect.

Some studies have also shown the great effectiveness of white vein kratom as a pain relief alternative when pain is severe.

The study, published in Annals of Internal Medicine, reviewed data on drug use and bowel cancer investigations drawn from prescription and patient registries in northern Denmark.

The scientists, led by Dr Soren Friis, from the Danish Cancer Society Research Centre, wrote: “Our results indicate that if aspirin is taken at doses of 75 to 150 mg, long-term, continuous use is necessary to achieve a substantial protective effect against colorectal (bowel) cancer.

“The potential use of aspirin and non-aspirin NSAIDs for the prevention of colorectal cancer is limited by the risk for gastrointestinal bleeding, and, for most nonaspirin NSAIDs, cardiovascular risks. These potential harms will need to be balanced against the chemopreventive benefits that our results indicate.”

Sorry we are not currently accepting comments on this article.

Leave a Reply

    Copyright 2011-2013, www.EHealthJournal.net, Web Site Development & SEO by SecondEffort, Inc.